As I pen my final letter as ICIS President, I reflect upon a busy and satisfying two years of shepherding this incredible organization that I am honored to be part of. Both of our annual meetings in Seoul, Korea and the present meeting in Seattle featured Nobel Laureates and Lasker [READ MORE]
The Nominations Committee is delighted to announce the results of the 2025 ICIS Leadership elections! Joining ICIS President-Elect Curt Horvath, Ph.D., Northwestern University, who ascends to the role of President next month, this year’s incoming leaders bring unique perspectives from across the globe and share a deep commitment to supporting [READ MORE]
I am a final year PhD candidate in the Beavis lab at the Peter MacCallum Cancer Centre in Melbourne, Australia. My research focuses on developing next-generation armoured CAR T cells with improved efficacy and safety using CRISPR/Cas9 technology. I am especially passionate about synthetic biology and cancer immunology, and how [READ MORE]
As we prepare for Cytokines 2025, we’re thrilled to spotlight one of our keynote speakers who has had what can only be described as an exceptional year of scientific recognition. While many of you know that Dr. Zhijian “James” Chen from UT Southwestern Medical Center received the 2024 Albert Lasker [READ MORE]
My name is Alexander Lercher, and I am currently a Postdoc in the lab of Charlie Rice at Rockefeller University in New York, and I am particularly excited about studying immune responses in the context of real-world microbe exposure. Out from the lab, my biggest hobby for the past years [READ MORE]
The Cytokines Society Annual Meeting is the only international meeting focusing specifically on cytokine biology – covering basic, translational, and clinical research specific to the role of cytokines in health and diseases. This meeting provides researchers from academia, government and industry the opportunity for networking and to engage with global [READ MORE]
ClinicalTrials.gov ID NCT06287528 Sponsor Memorial Sloan Kettering Cancer Center Information provided by Memorial Sloan Kettering Cancer Center (Responsible Party) Last Update Posted 2025-05-21 Study Overview Brief Summary Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells [READ MORE]
ClinicalTrials.gov ID NCT06321484 Sponsor Dana-Farber Cancer Institute Information provided by Rebecca Porter, MD, PhD, Dana-Farber Cancer Institute (Responsible Party) Last Update Posted 2024-11-01 Study Overview Brief Summary The goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) [READ MORE]
ClinicalTrials.gov ID NCT06713044 Sponsor Universitas Jenderal Soedirman Information provided by Guruh Perkasa, Universitas Jenderal Soedirman (Responsible Party) Last Update Posted 2024-12-03 Study Overview Brief Summary The goal of this study is to determine the effect of murottal and classical music on postoperative pain intensity and interleukin 6 levels in patients [READ MORE]
We are delighted to announce two exceptional researchers who will deliver the prestigious memorial lectures at Cytokines 2025 – the 13th Annual Meeting of the International Cytokine & Interferon Society. Dr. Susan Kaech from the Salk Institute for Biological Studies will present the Philip I. Marcus Memorial Lecture, while Dr. [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
